Proteostasis Therapeutics Obtains $10,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b33df6ac-5407-4c3d-b2b2-78366217c0e1
Date
9/16/2015
Company Name
Proteostasis Therapeutics
Mailing Address
200 Technology Square 4th Floor Cambridge, MA 02139 USA
Company Description
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases.
Website
http://www.proteostasis.com
Transaction Type
Debt
Transaction Amount
$10,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed